Edition:
United States

People: NeuroMetrix Inc (NURO.O)

NURO.O on Consolidated Issue listed on NASDAQ Capital Market

1.56USD
26 Sep 2016
Change (% chg)

$-0.04 (-2.60%)
Prev Close
$1.60
Open
$1.61
Day's High
$1.61
Day's Low
$1.55
Volume
40,887
Avg. Vol
89,155
52-wk High
$3.72
52-wk Low
$1.35

Katz, Nancy 

Ms. Nancy E. Katz is Independent Director of NeuroMetrix Inc., since December 14, 2010. Since May 2011, Ms. Katz has served as Vice President, Consumer Marketing and Market Development at Medtronic, Inc., a medical technology company. From July 2005 to July 2010, Ms. Katz was Senior Vice President, Bayer Diabetes Care—North America. Prior to this position, she was President and Chief Executive Officer of Calypte Biomedical Corporation, a manufacturer of HIV diagnostics, President of Zila Pharmaceutical, Inc, a manufacturer of oral care products, and held senior marketing positions with the Lifescan division of Johnson & Johnson (blood glucose diabetes products), Schering-Plough Healthcare Products, and with American Home Products. She has previously served on the Boards of Directors of Neoprobe Corporation (AMEX: NEOP), Calypte Biomedical Corporation, LXN Corporation and Pepgen Corporation. Ms. Katz received a B.S. in business from the University of South Florida.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --